Bepa Pavlić | Clinical Research | Research Excellence Award

Research Excellence Award

Bepa Pavlić
University Hospital Centre Split
Bepa Pavlić
Affiliation University Hospital Centre Split
Country Croatia
Google Scholar bxqWC-YAAAAJ
Documents 10
Citation 1
h-index 1
Subject Area Clinical Research
Event Research Awards and Recognitions
Scopus 60212969000

Bepa Pavlić is a Croatian medical doctor and dermatology researcher affiliated with the University Hospital Centre Split. Her academic and clinical activities focus on dermatology, venereology, hidradenitis suppurativa, psoriasis, dermoscopy, inflammatory skin disorders, and interdisciplinary clinical research. Through conference participation, collaborative publications, and involvement in international dermatological organizations, Pavlić has contributed to emerging clinical discussions concerning inflammatory dermatoses, biologic therapies, and patient-centered dermatological care.[1]

Abstract

This article documents the academic profile, clinical activities, and scholarly contributions of Bepa Pavlić, a Croatian physician specializing in dermatology and venereology. Her work reflects ongoing participation in dermatological education, scientific conferences, interdisciplinary collaborations, and peer-reviewed clinical research. Pavlić has contributed to studies concerning hidradenitis suppurativa, psoriasis, scabies, melanoma, treatment adherence, and inflammatory skin diseases. Her publication portfolio demonstrates engagement with both clinical case reports and translational dermatological research.[2]

Keywords

Dermatology, Venereology, Clinical Research, Psoriasis, Hidradenitis Suppurativa, Melanoma, Dermoscopy, Croatian Medical Research, Biologic Therapy, Academic Medicine.

Introduction

Bepa Pavlić has developed a clinical and academic trajectory within Croatian dermatology through medical practice, conference participation, continuing education, and collaborative scientific publication. Following completion of her Doctor of Medicine degree at the University of Zagreb School of Medicine in 2020, she worked as a general practitioner before commencing specialization in dermatology and venereology at the University Hospital Centre Split in 2022.[3]

Her subsequent enrollment as a PhD candidate at the University of Split School of Medicine reflects an expansion of her academic involvement into research-oriented clinical investigation. Her work spans inflammatory dermatological diseases, dermoscopy, biologic therapy evaluation, treatment adherence, and multidisciplinary patient management.[4]

Research Profile

Pavlić’s academic profile combines clinical dermatology practice with emerging scholarly activity in translational and observational dermatological research. Her participation in scientific meetings across Croatia and Europe has included conferences organized by the European Academy of Dermatology and Venereology (EADV), the European Hidradenitis Suppurativa Foundation (EHSF), and IUSTI Europe.[5]

Her research interests include hidradenitis suppurativa, psoriasis, biologic therapies, melanoma surveillance, skin infections, dermoscopy, and treatment adherence. These themes recur throughout her publications and conference presentations, indicating a sustained interest in evidence-based dermatological practice and patient-centered care models.[6]

In addition to research activity, Pavlić has participated in continuing medical education programs involving infectology, dermoscopy, sexually transmitted infections, skin cancer diagnostics, and advanced dermatovenerology. Such educational participation supports ongoing professional development within specialized dermatological practice.[7]

Research Contributions

Among Pavlić’s notable research contributions are studies examining inflammatory dermatological disorders and biologic therapy outcomes. Collaborative research on hidradenitis suppurativa explored vascular changes associated with adalimumab treatment and investigated systemic therapeutic approaches in severe disease manifestations.[8]

Her publications also address diagnostic dermatology and clinical case management, including reports concerning scabies surrepticius, Bowen’s disease, neuroendocrine tumor-related pruritus, epidermal nevus misdiagnosis, and melanoma surveillance. These works contribute to clinical awareness regarding atypical presentations and multidisciplinary management strategies.[9]

Additional contributions concern psychosocial and behavioral dimensions of dermatological care. Research involving treatment adherence among psoriasis patients and parents of children with atopic dermatitis reflects interest in patient behavior, therapeutic perception, and long-term clinical outcomes.[10]

Publications

  • Removing the Mask of Scabies Surrepticius with Guidelines: A Nodular Scabies Case Report (2023)
  • Is TNF-Alpha Inhibitor Therapy a Good Choice for Patients with Concomitant Hidradenitis Suppurativa and Psoriasis Vulgaris? (2023)
  • Gastrointestinal Neuroendocrine Tumour as a Cause of Pruritus in a Patient with Neurofibromatosis Type 1 (2023)
  • Are We Good Enough in Recognizing Scalp Lesions? (2023)
  • The Effect of Adalimumab Treatment on the Vascularization of Hidradenitis Suppurativa Lesions: A Pilot Study (2024)
  • When Topical Treatment Surprises: A Case Report of Bowen’s Disease in the Perianal Region (2024)
  • Beliefs About Medicines and Adherence to Biologic Therapy in Patients with Moderate-to-Severe Psoriasis: A Cross-Sectional Study (2025)
  • Personality Traits and Treatment Adherence Among Parents of Children with Atopic Dermatitis (2026)
  • Adalimumab Treatment Modulates Vascular Changes in Hidradenitis Suppurativa Lesions in a Sex-Dependent Manner (2026)
  • Bridging Skin and Kidney: IL-17A Blockade for Refractory Hidradenitis Suppurativa in a Hemodialyzed Young Adult (2026)

Research Impact

The research impact associated with Pavlić’s work derives primarily from collaborative clinical publications, participation in specialized dermatological conferences, and contributions to discussions regarding hidradenitis suppurativa, biologic therapy, and dermatological diagnostics. Her work demonstrates engagement with clinically relevant dermatological challenges affecting patient outcomes and therapeutic management.[11]

Her involvement in studies published through journals such as Medicina and Biomedicines further reflects participation in internationally indexed biomedical research dissemination. These activities contribute to the broader exchange of dermatological knowledge within European clinical research networks.[12]

Award Suitability

Bepa Pavlić’s profile aligns with criteria commonly associated with emerging clinical research recognition, particularly in the areas of dermatology, interdisciplinary medical collaboration, and continuing professional development. Her documented engagement with scientific publishing, conference participation, and specialized clinical education indicates sustained scholarly activity within dermatovenerology.[13]

The combination of active clinical service, postgraduate academic development, and participation in international dermatological organizations further supports recognition within research and professional achievement programs focused on early-career medical researchers.[14]

Conclusion

Bepa Pavlić represents an emerging contributor within Croatian and European dermatological research communities. Through collaborative clinical studies, continuing education, scientific conference participation, and interdisciplinary publication activity, her work reflects ongoing engagement with contemporary dermatological challenges and evidence-based medical practice. Her academic progression and clinical research participation position her within a growing network of physician-researchers contributing to advances in dermatology and venereology.[15]

References

  1. Google Scholar. (n.d.). Bepa Pavlić Scholar Profile. https://scholar.google.com/citations?user=bxqWC-YAAAAJ&hl=en&oi=sra
  2. Elsevier. (n.d.). Scopus author details: Bepa Pavlić, Author ID 60212969000. Scopus. https://www.scopus.com/authid/detail.uri?authorId=60212969000
  3. University of Zagreb School of Medicine. (2020). Doctor of Medicine Graduation Record.
  4. University of Split School of Medicine. (2025). PhD Candidate Enrollment Information.
  5. European Academy of Dermatology and Venereology (EADV). (2023). Professional Membership Information. https://www.eadv.org/
  6. European Hidradenitis Suppurativa Foundation. (2024). Conference and Research Activities. https://ehsf.eu/
  7. University Hospital Centre Split. (2022–2026). Continuing Medical Education and Dermatology Training Activities.
  8. Vuković, D., Pavlić, B., et al. (2024). The Effect of Adalimumab Treatment on the Vascularization of Hidradenitis Suppurativa Lesions: A Pilot Study.
  9. Pavlić, B., et al. (2024). When Topical Treatment Surprises: A Case Report of Bowen’s Disease in the Perianal Region.
  10. Pavić, M., et al. (2025). Beliefs About Medicines and Adherence to Biologic Therapy in Patients with Moderate-to-Severe Psoriasis: A Cross-Sectional Study. https://doi.org/10.3390/medicina61010001
  11. Pavlić, B., et al. (2026). Adalimumab Treatment Modulates Vascular Changes in Hidradenitis Suppurativa Lesions in a Sex-Dependent Manner. Biomedicines. https://doi.org/10.3390/biomedicines14010001
  12. MDPI. (2026). Biomedicines Special Issue: Pathophysiology and Therapeutic Innovations in Skin and Appendage Disorders. https://www.mdpi.com/journal/biomedicines
  13. Research Awards and Recognitions. (n.d.). Academic Recognition and Research Excellence Programs. https://awardsandrecognitions.com/
  14. Croatian Dermatovenerological Society. (2023). Professional Society Membership Record.
  15. European clinical dermatology conference proceedings and collaborative publications associated with Bepa Pavlić between 2023 and 2026.

Goksen Goren | Pharmacology | Best Researcher Award

Mrs. Goksen Goren | Pharmacology | Best Researcher Award

Mrs. Goksen Goren | Pharmacology – Lecturer at İstinye University | Turkey

Mrs. Göksen Gören is a distinguished researcher at İstinye University, specializing in Biotechnology and Molecular Biology with a particular focus on cell culture, enzyme purification, and molecular assay development. She completed her Ph.D. in Biotechnology from a renowned international university, where she gained extensive expertise in bioprocessing and applied molecular techniques. Over her professional career, Mrs. Gören has contributed to numerous national and international research projects, demonstrating her ability to integrate multidisciplinary approaches to solve complex biological problems. Her research interests include thermophilic enzyme purification, microbial biotechnology, and molecular mechanisms in cell cultures, and she possesses advanced technical skills in protein isolation, molecular characterization, and laboratory data analysis. Mrs. Gören has authored multiple high-impact publications indexed in Scopus and IEEE, reflecting her growing influence in the scientific community. She actively participates in international conferences and workshops, promoting collaboration and knowledge dissemination. She is also an active member of professional societies such as IEEE and ACM, highlighting her commitment to advancing research standards and professional networking. Among her achievements, Mrs. Gören has been recognized for innovation in biochemical methodologies and contributions to applied molecular research, earning her awards and honors that underscore her academic excellence and leadership in the field. Her strengths lie in her methodological rigor, analytical problem-solving, and mentorship of early-career researchers, while areas for further growth include expanding international collaborations and increasing her publications in high-impact journals to enhance global visibility.

Academic Profile: Google Scholar

Featured Publications:

  1. Aras, S., Altıntas, R., Aygun, E., Gören, G., & Sisecioglu, M. (2025). Purification of α-amylase from thermophilic Bacillus licheniformis SO5 by using a novel method, alternating current magnetic-field assisted three-phase partitioning. Food Chemistry, 484, 144258. Citation: 5

 

 

Prof. Yuqiang Xiang | Biosensors | Best Researcher Award

Prof. Yuqiang Xiang | Biosensors | Best Researcher Award

Prof. Yuqiang Xiang | Biosensors – Professor at Henan Agriculture University, China

Dr. Yuqiang Xiang is an accomplished researcher renowned for his contributions to the fields of nanomaterials, biosensing technology, and veterinary diagnostics. With a dynamic academic background and a multidisciplinary approach, Dr. Xiang has established himself as a forward-thinking scientist whose research integrates chemistry, biology, and environmental sciences. His dedication to scientific excellence, combined with a consistent record of high-quality publications, underpins his growing reputation in the global research community.

Profile Verified:

Orcid | Scopus

Education:

Dr. Xiang completed his higher education with a strong emphasis on biotechnology, nanoscience, and analytical chemistry. Throughout his academic journey, he has cultivated a profound understanding of molecular biology, material science, and environmental toxicology, which form the backbone of his research innovations. His rigorous training provided him with the technical skills and theoretical foundation essential for addressing complex biological and environmental challenges through cutting-edge material design and diagnostic technology.

Experience:

Throughout his professional career, Dr. Xiang has been actively engaged in both academic research and practical scientific applications. His affiliation with Henan Agricultural University has allowed him to collaborate with leading scientists on projects ranging from biosensor development to veterinary disease diagnostics. With experience spanning laboratory innovation, interdisciplinary project management, and peer-reviewed publishing, Dr. Xiang has built a career that reflects a balanced emphasis on academic theory and practical application. His participation in peer-review activities also demonstrates his role in upholding the quality and integrity of scientific communication.

Research Interests:

Dr. Xiang’s research interests lie at the intersection of nanotechnology, biosensors, microbial composites, veterinary virology, and environmental health. His work primarily focuses on developing novel nanomaterials for multiplex bioassays, understanding biofilm architectures, and designing cost-effective diagnostic tools for animal health. Driven by a passion for innovation, he strives to create scientific solutions that enhance diagnostic accuracy, environmental safety, and public health. His recent endeavors into the synthesis of metal-organic frameworks and fluorescent biomaterials highlight his commitment to translational research that bridges fundamental science with real-world applications.

Awards:

While formal documentation of prestigious awards is limited at this stage, Dr. Xiang’s substantial contributions, citation records, and active research output position him as a strong candidate for recognition through awards like the “Best Researcher Award.” His work has consistently received acknowledgment through journal acceptances in competitive, peer-reviewed international platforms, which itself stands as testament to the quality and impact of his contributions.

Publications:

Dr. Xiang has authored numerous impactful papers in reputed journals, with select notable works including:

📘 “Biomimetic Assembly of Spore@ZIF-8 Microspheres for Vaccination” (Small, 2022, cited by 10 articles),
📙 “Unique Fluorescent Protein-Encoded Microbeads with Supramaximal Encoding Capacity and High Sensitivity for Multiplex Bioassays” (Analytical Chemistry, 2023, cited by 5 articles),
📗 “Porcine β-defensin-2 Alleviates AFB1-Induced Intestinal Mucosal Injury” (Ecotoxicology and Environmental Safety, 2023, cited by 8 articles),
📕 “The Coexistence of Bacterial Species Restructures Biofilm Architecture and Increases Tolerance to Antimicrobial Agents” (Microbiology Spectrum, 2023, cited by 6 articles),
📓 “Development and Application of a Low-Priced Duplex Quantitative PCR Assay” (Veterinarni Medicina, 2023, cited by 3 articles),
📔 “Microorganisms@aMIL-125 (Ti): An Amorphous Metal-Organic Framework Induced by Microorganisms” (ACS Omega, 2022, cited by 7 articles),
 📒 “Aflatoxin B1 Disrupts the Intestinal Barrier Integrity by Reducing Junction Protein and Promoting Apoptosis” (Ecotoxicology and Environmental Safety, 2022, cited by 12 articles).

Conclusion:

In conclusion, Dr. Yuqiang Xiang exemplifies the qualities of a Best Researcher Award nominee through his interdisciplinary expertise, consistent scholarly output, and innovative research contributions. His work bridges critical gaps between material science, diagnostics, and environmental health, making significant strides toward practical, scalable solutions in veterinary medicine and environmental protection. With a trajectory that shows continuous growth, collaboration, and scientific rigor, Dr. Xiang is poised to further enhance his impact in the scientific community. Recognizing his achievements through this award would not only honor his past contributions but also encourage his continued pursuit of excellence in research.